FDA Plan B Review Warrants Lawsuit, Wisconsin Attorney General Says
This article was originally published in The Pink Sheet Daily
Executive Summary
Plan B delay merits lawsuit due to adverse effect on state resources, Wisconsin AG asserts. Letter to Governor maintains FDA’s “unreasonable delay” on switch decision constitutes “arbitrary, capricious” actions.
You may also be interested in...
Fraud Discovery Institute Asks Waxman To Address Lead In Herbalife Products
FDA should issue a public health alert to warn consumers about potential health risks that may result from use of Herbalife dietary supplements and should remove the company's products from the market, pending further investigation of lead contamination, according to Christopher Grell, an attorney whose firm specializes in ephedra and dietary supplement litigation
Fraud Discovery Institute Asks Waxman To Address Lead In Herbalife Products
FDA should issue a public health alert to warn consumers about potential health risks that may result from use of Herbalife dietary supplements and should remove the company's products from the market, pending further investigation of lead contamination, according to Christopher Grell, an attorney whose firm specializes in ephedra and dietary supplement litigation
Commercialization Phase Brings New Challenges To Nanotech Industry
Increased industry/government collaboration is needed in the field of nanotechnology to move from the research & development phase to the comercialization phase, speakers told the President's Council of Advisors on Science and Technology (PCAST) during a June 25 meeting in Arlington, Va
Need a specific report? 1000+ reports available
Buy Reports
Register for our free email digests: